logo
  Home | Contact us | Browse | Quick Search by UniProtKB ID, Keyword, PDBID

Menu:

Latest news:

Sep. 10, 2014:
A total of 174 experimentally verified S-nitrosylation sites on 94 S-nitrosylated proteins from individualized human colorectal cancer tissues using a label-free quantitation strategy.

Read more...


Protein Name: RAC-alpha serine/threonine-protein kinase

UniprotKB/SwissProt ID: AKT1_HUMAN (P31749)

Gene Name: AKT1

Synonyms: PKB, RAC

Organism: Homo sapiens (Human).

Function: AKT1 is one of 3 closely related serine/threonine- protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis. This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates. Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported. AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface. Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling. Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport. AKT regulates also the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity. Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven. AKT regulates also cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating mTORC1 signaling and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1. AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization. In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319'. FOXO3 and FOXO4 are phosphorylated on equivalent sites. AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)- response element binding protein). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1. AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis. Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis. Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity. The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth. AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation. Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor I (IGF-I). AKT mediates the antiapoptotic effects of IGF-I. Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly. May be involved in the regulation of the placental development. Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3. Phosphorylates STK3/MST2 at 'Thr- 117' and 'Thr-384' leading to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation. Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation. Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity. Phosphorylation of BAD stimulates its pro- apoptotic activity. Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53. AKT1-specific substrates have been recently identified, including palladin (PALLD), which phosphorylation modulates cytoskeletal organization and cell motility; prohibitin (PHB), playing an important role in cell metabolism and proliferation; and CDKN1A, for which phosphorylation at 'Thr-145' induces its release from CDK2 and cytoplasmic relocalization. These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation. Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation.

Other Modifications: View all modification sites in dbPTM

Protein Subcellular Localization: Cytoplasm. Nucleus. Cell membrane. Note=Nucleus after activation by integrin-linked protein kinase 1 (ILK1). Nuclear translocation is enhanced by interaction with TCL1A. Phosphorylation on Tyr-176 by TNK2 results in its localization to the cell membrane

PDB :
( If your security settings prevent Jmol from running, please register http://140.138.144.145/ as a safe location in your Java settings. )

Protein disease:
Disease database Database Entry Disease information
KEGGH00539 PTEN hamartoma tumor syndrome (PHTS), including: Cowden syndrome; Bannayan-Riley-Ruvalcaba syndrome;
KEGGH00020 Colorectal cancer
OMIM114480BREAST CANCER ;;BREAST CANCER, FAMILIAL BREAST CANCER, FAMILIAL MALE, INCLUDED
OMIM114500COLORECTAL CANCER; CRC ;;COLON CANCER
OMIM164730V-AKT MURINE THYMOMA VIRAL ONCOGENE HOMOLOG 1; AKT1 ;;ONCOGENE AKT1;; PROTEIN KINASE B-ALPHA
OMIM176920PROTEUS SYNDROME ;;GIGANTISM, PARTIAL, OF HANDS AND FEET, NEVI, HEMIHYPERTROPHY, AND MACROCE
OMIM181500SCHIZOPHRENIA; SCZD ;;SCHIZOAFFECTIVE DISORDER, INCLUDED
OMIM615109COWDEN SYNDROME 6; CWS6
Network with metabolic pathway:
Kegg map ID Pathway Link
map04664Fc epsilon RI signaling pathway
map04973Carbohydrate digestion and absorption
map05213Endometrial cancer
map05221Acute myeloid leukemia
map05223Non-small cell lung cancer
map04066HIF-1 signaling pathway
map04210Apoptosis
map04370VEGF signaling pathway
map04380Osteoclast differentiation
map04660T cell receptor signaling pathway
map04662B cell receptor signaling pathway
map04666Fc gamma R-mediated phagocytosis
map04722Neurotrophin signaling pathway
map04725Cholinergic synapse
map04728Dopaminergic synapse
map04920Adipocytokine signaling pathway
map05142Chagas disease (American trypanosomiasis)
map05145Toxoplasmosis
map05160Hepatitis C
map05162Measles
map05210Colorectal cancer
map05211Renal cell carcinoma
map05212Pancreatic cancer
map05214Glioma
map05215Prostate cancer
map05218Melanoma
map05220Chronic myeloid leukemia
map05222Small cell lung cancer
map04010MAPK signaling pathway
map04012ErbB signaling pathway
map04062Chemokine signaling pathway
map04150mTOR signaling pathway
map04151PI3K-Akt signaling pathway
map04510Focal adhesion
map04530Tight junction
map04620Toll-like receptor signaling pathway
map04630Jak-STAT signaling pathway
map04910Insulin signaling pathway
map04914Progesterone-mediated oocyte maturation
map05152Tuberculosis
map05161Hepatitis B
map05164Influenza A
map05166HTLV-I infection
map05169Epstein-Barr virus infection
map05200Pathways in cancer
Graphical Visualization of S-nitrosylation Sites:
Overview of Protein S-nitrosylation Sites with Functional and Structural Information
InterPro ID Domain
IPR000719
IPR000961
IPR001849
IPR002290
IPR008271
IPR011009
IPR011993
IPR015744

3D Structure Databases:
3D structure databases
EntryMethodResolution (A)ChainPositionsView
1H10 X-ray 1.40 A A1-123Link
1UNP X-ray 1.65 A A1-121Link
1UNQ X-ray 0.98 A A1-123Link
1UNR X-ray 1.25 A A1-123Link
2UVM X-ray 1.94 A A1-123Link
2UZR X-ray 1.94 A A1-123Link
2UZS X-ray 2.46 A A1-123Link
3CQU X-ray 2.20 A A144-480Link
3CQW X-ray 2.00 A A144-480Link
3MV5 X-ray 2.47 A A144-480Link
3MVH X-ray 2.01 A A144-480Link
3O96 X-ray 2.70 A A2-443Link
3OCB X-ray 2.70 A A/B144-480Link
3OW4 X-ray 2.60 A A/B144-480Link
3QKK X-ray 2.30 A A144-480Link
3QKL X-ray 1.90 A A144-480Link
3QKM X-ray 2.20 A A144-480Link
4EJN X-ray 2.19 A A2-446Link
4EKK X-ray 2.80 A A/B144-480Link
4EKL X-ray 2.00 A A144-480Link
4GV1 X-ray 1.49 A A144-480Link

The S-nitrosylation sites of AKT1_HUMAN

No. Position S-nitrosylated Peptide Secondary Structure of S-nitrosylated Peptide Solvent Accessibility of nitrosylated Site Substrate Motifs PubMed ID Experiment
1224KYSFQTHDRL C FVMEYANGGE EEEEEECCEE E EEEEECCCCH 2.23%HC0322178444-
2224KYSFQTHDRL C FVMEYANGGE EEEEEECCEE E EEEEECCCCH 2.23%HC0315632167-
3296GHIKITDFGL C KEGIKDGATM CCEEEEECHH H HHHCCCCCEE 3.74%HC1122178444-
4296GHIKITDFGL C KEGIKDGATM CCEEEEECHH H HHHCCCCCEE 3.74%HC1116041729-
5310IKDGATMKTF C GTPEYLAPEV CCCCCEEEEE C CCHHHCCHHH 7.79%HC0422178444-
6310IKDGATMKTF C GTPEYLAPEV CCCCCEEEEE C CCHHHCCHHH 7.79%HC0416041729-